40 studies found for:    " October 05, 2011":" November 04, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" October 05, 2011":" November 04, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac)
Conditions: Human Immunodeficiency Virus (HIV);   HIV Associated Neurocognitive Disorders (HAND)
Intervention: Drug: Maraviroc
2 Terminated
Has Results
A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV
Conditions: Human Immunodeficiency Virus (HIV);   HIV Associated Neurocognitive Disorders (HAND)
Intervention: Drug: Raltegravir
3 Active, not recruiting A Commitment Device for Medication Adherence Among HIV Patients
Conditions: Acquired Immunodeficiency Syndrome;   HIV
Intervention: Other: Medication Adherence among HIV/AIDS Patients
4 Completed Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: Darunavir/Ritonavir (DRV/r);   Drug: Lopinavir in fixed combination with Ritonavir;   Drug: Zidovudine;   Drug: NRTIs;   Drug: Efavirenz
5 Completed Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural Lesotho
Conditions: HIV/AIDS;   Tuberculosis;   Diabetes Mellitus;   Arterial Hypertension
Interventions: Other: Door-to-door;   Other: Pitso
6 Unknown  Bioequivalence Study of Pediatric Formulations to Treat HIV Infection
Conditions: HIV;   AIDS
Interventions: Drug: Epivir®, Retrovir® and Viramune®;   Drug: Lamivudine, Zidovudine and nevirapine;   Drug: Lamivudine, zidovudine, nevirapine
7 Completed Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant
Condition: HIV Infection
Interventions: Biological: Vacc-4x low dose;   Biological: Vacc-4x medium dose;   Biological: Vacc-4x high dose;   Biological: Zero dose
8 Completed Atazanavir/Ritonavir and Zinc Pharmacokinetic Study
Condition: HIV Infection
Interventions: Drug: 1 Solvazinc tablet, day 2 to day 15;   Drug: 1 Solvazinc tablet, day 15 to day 28
9 Withdrawn Trial of Probiotics to Lower Microbial Translocation and Immune Activation in HIV-Infected Adolescents
Condition: HIV Infection
Interventions: Dietary Supplement: Probiotics;   Dietary Supplement: Placebo
10 Recruiting Early Antiviral Therapy for Critically Ill HIV Infected Patients
Condition: HIV Infection
Interventions: Drug: early HAART;   Drug: Late HAART
11 Completed Efficacy of Raltegravir in a Large Urban HIV Clinical Population in Milan
Condition: HIV Infections
Intervention:
12 Recruiting RAltegravir Switch STudy: Effects on Endothelial Recovery
Conditions: HIV Infection;   Endothelial Dysfunction
Intervention: Drug: raltegravir
13 Unknown  Maternal-fetal CD4 Microchimerism in HiV Exposed Newborns After Spontaneous Delivery and Cesarean Section
Condition: Human Immunodeficiency Virus
Intervention:
14 Recruiting Comorbidity and Aging With HIV
Conditions: HIV-1-infection;   Comorbidity;   Ageing
Intervention:
15 Active, not recruiting Problems With Immune Recovery in the Gut Tissue
Condition: Human Immunodeficiency Virus
Intervention: Procedure: Genital and rectal swabbing
16 Recruiting Tissue Drug Levels of HIV Medications
Condition: Human Immunodeficiency Virus
Intervention: Drug: Initiation of anti-retroviral therapy
17 Active, not recruiting
Has Results
Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: dolutegravir 50 mg OAD;   Drug: darunavir 800mg OAD;   Drug: ritonavir 100mg OAD
18 Completed A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects
Condition: Infections, Human Immunodeficiency Virus and Hepatitis
Interventions: Drug: Dolutegravir;   Drug: Rlipivirine;   Drug: GSK1265744
19 Completed Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV
Condition: HIV Infection
Intervention:
20 Completed Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract
Conditions: Women's Health;   HIV Infection;   Genital Diseases, Female
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years